Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michael J. Abrahamson"'
Autor:
Ryan M. Phelan, Michael J. Abrahamson, Jesse T. C. Brown, Ruijie K. Zhang, Christian R. Zwick
Publikováno v:
Organic Process Research & Development. 26:1944-1959
Autor:
Rodger F. Henry, Chen Ding, Sanjay R. Chemburkar, Shuang Chen, Hongqiang Zhang, Nandkishor K. Nere, Jianzhang Mei, Kirill A. Lukin, Rajarathnam E. Reddy, David R. Hill, Matthew J. Pelc, Angelica B. Kielbus, Timothy B. Towne, Michael J. Abrahamson, Kenneth M. Engstrom, Russell D. Cink
Publikováno v:
Organic Process Research & Development. 24:1393-1404
The preceding article described the development of the large-scale synthetic route to macrocycle 3 of glecaprevir (1), a potent HCV protease inhibitor. This article describes the development of the...
Publikováno v:
Advanced Synthesis & Catalysis. 355:1780-1786
The reductive amination of ketones to produce chiral amines is an important transformation in the production of pharmaceutical intermediates. Therefore, industrially applicable enzymatic methods that enable the selective synthesis of chiral amines co
Autor:
Nicholas B. Woodall, Andreas S. Bommarius, Eduardo Vazquez-Figueroa, Jeffrey C. Moore, Michael J. Abrahamson
Publikováno v:
Angewandte Chemie International Edition. 51:3969-3972
A leucine dehydrogenase has been successfully altered through several rounds of protein engineering to an enantioselective amine dehydrogenase. Instead of the wild-type α-keto acid, the new amine dehydrogenase now accepts the analogous ketone, methy
Autor:
Nicholas B. Woodall, Michael J. Abrahamson, Andreas S. Bommarius, Eduardo Vazquez-Figueroa, Jeffrey C. Moore
Publikováno v:
Angewandte Chemie. 124:4036-4040
Publikováno v:
Current Opinion in Chemical Biology. 15:194-200
Recent advances in the development of both experimental and computational protein engineering tools have enabled a number of further successes in the development of biocatalysts ready for large-scale applications. Key tools are first, the targeting o
Autor:
Bettina Bommarius, Andreas S. Bommarius, Samantha K. Au, Michael J. Abrahamson, Martin Schuermann
Publikováno v:
The FASEB Journal. 28
Recently, we obtained the first amine dehydrogenases, termed L-AmDH and F-AmDH, from leucine DH [1] and phenylalanine DH [2], respectively, allowing direct reductive amination of ketones to chiral amines. Starting from a scaffold devoid of such activ
Publikováno v:
Journal of colloid and interface science. 315(1)
Approximately 90% of all ophthalmic drug formulations are now applied as eye-drops. While eye-drops are convenient and well accepted by patients, about 95% of the drug contained in the drops is lost due to absorption through the conjunctiva or throug